Related references
Note: Only part of the references are listed.Angiotensin II receptor blockers decrease serum concentration of fatty acid-binding protein 4 in patients with hypertension
Masato Furuhashi et al.
HYPERTENSION RESEARCH (2015)
Secretion of fatty acid binding protein aP2 from adipocytes through a nonclassical pathway in response to adipocyte lipase activity
Meric Erikci Ertunc et al.
JOURNAL OF LIPID RESEARCH (2015)
FABP4 is Secreted from Adipocytes by Adenyl Cyclase-PKA- and Guanylyl Cyclase-PKG-Dependent Lipolytic Mechanisms
Tomohiro Mita et al.
OBESITY (2015)
Ectopic Expression of Fatty Acid-Binding Protein 4 in the Glomerulus Is Associated with Proteinuria and Renal Dysfunction
Marenao Tanaka et al.
NEPHRON CLINICAL PRACTICE (2014)
Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general population
Takahiro Fuseya et al.
CARDIOVASCULAR DIABETOLOGY (2014)
The influence of EPA and DHA on markers of inflammation in 3T3-L1 cells at different stages of cellular maturation
Adam Prostek et al.
LIPIDS IN HEALTH AND DISEASE (2014)
Urinary Excretion of Fatty Acid-Binding Protein 4 is Associated with Albuminuria and Renal Dysfunction
Yusuke Okazaki et al.
PLOS ONE (2014)
Capillary Endothelial Fatty Acid Binding Proteins 4 and 5 Play a Critical Role in Fatty Acid Uptake in Heart and Skeletal Muscle
Tatsuya Iso et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Association between ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cardiovascular disease: The Hisayama Study
Toshiharu Ninomiya et al.
ATHEROSCLEROSIS (2013)
Adipocyte Lipid Chaperone aP2 Is a Secreted Adipokine Regulating Hepatic Glucose Production
Haiming Cao et al.
CELL METABOLISM (2013)
FABP4 Induces Vascular Smooth Muscle Cell Proliferation and Migration through a MAPK-Dependent Pathway
Josefa Girona et al.
PLOS ONE (2013)
Circulating Levels of Fatty Acid-Binding Protein Family and Metabolic Phenotype in the General Population
Shutaro Ishimura et al.
PLOS ONE (2013)
Circulating and Dietary Omega-3 and Omega-6 Polyunsaturated Fatty Acids and Incidence of CVD in the Multi-Ethnic Study of Atherosclerosis
Marcia C. de Oliveira Otto et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Elevation of Fatty Acid-Binding Protein 4 Is Predisposed by Family History of Hypertension and Contributes to Blood Pressure Elevation
Hideki Ota et al.
AMERICAN JOURNAL OF HYPERTENSION (2012)
Circulating Adipocyte Fatty Acid-Binding Protein Levels and Cardiovascular Morbidity and Mortality in Patients With Coronary Heart Disease A 10-year Prospective Study
Maximilian von Eynatten et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells
Gemma Aragones et al.
CARDIOVASCULAR DIABETOLOGY (2012)
Unsaturated fatty acids repress the expression of adipocyte fatty acid binding protein via the modulation of histone deacetylation in RAW 264.7 macrophages
Sara L. Coleman et al.
EUROPEAN JOURNAL OF NUTRITION (2011)
Olmesartan reduces arterial stiffness and serum adipocyte fatty acid-binding protein in hypertensive patients
Toru Miyoshi et al.
HEART AND VESSELS (2011)
Dietary constituents reduce lipid accumulation in murine C3H10 T1/2 adipocytes: A novel fluorescent method to quantify fat droplets
Ines Warnke et al.
NUTRITION & METABOLISM (2011)
Serum Fatty Acid-Binding Protein 4 Is a Predictor of Cardiovascular Events in End-Stage Renal Disease
Masato Furuhashi et al.
PLOS ONE (2011)
Lipid Chaperones and Metabolic Inflammation
Masato Furuhashi et al.
INTERNATIONAL JOURNAL OF INFLAMMATION (2011)
Suppressive actions of eicosapentaenoic acid on lipid droplet formation in 3T3-L1 adipocytes
Elizabeth Manickam et al.
LIPIDS IN HEALTH AND DISEASE (2010)
Revised Equations for Estimated GFR From Serum Creatinine in Japan
Seiichi Matsuo et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Adipocyte Fatty Acid-Binding Protein Suppresses Cardiomyocyte Contraction A New Link Between Obesity and Heart Disease
Valeria Lamounier-Zepter et al.
CIRCULATION RESEARCH (2009)
Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells
Harun Elmasri et al.
FASEB JOURNAL (2009)
Dietary fish and ω-3 fatty acid consumption and heart rate variability in US adults
Dariush Mozaffarian et al.
CIRCULATION (2008)
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Luigi Tavazzi et al.
LANCET (2008)
Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets
Masato Furuhashi et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Genomic changes in regenerated porcine coronary arterial endothelial cells
Mary Y. K. Lee et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis
D. C. Y. Yeung et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Treatment with atorvastatin reduces serum adipocyte-fatty acid binding protein value in patients with hyperlipidaemia
M. Karpisek et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2
Masato Furuhashi et al.
NATURE (2007)
Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome - A 5-year prospective study
Aimin Xu et al.
CIRCULATION (2007)
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised openlabel, blinded endpoint analysis
Mitsuhiro Yokoyama et al.
LANCET (2007)
Adipocyte differentiation from the inside out
Evan D. Rosen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome
AM Xu et al.
CLINICAL CHEMISTRY (2006)
Effect of fish oil on heart rate in humans - A meta-analysis of randomized controlled trials
D Mozaffarian et al.
CIRCULATION (2005)
Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes
K Maeda et al.
CELL METABOLISM (2005)
Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis
L Makowski et al.
NATURE MEDICINE (2001)
Share Paper
